Antitrust

CCI approves acquisition of Corporate restructuring of GlaxoSmithKline Consumer Healthcare Holdings (No.2) Limited (“JVCO”) under Section 31(1) of the Competition Act, 2002

CCI approves acquisition of Corporate restructuring of GlaxoSmithKline Consumer
Healthcare Holdings (No.2) Limited (“JVCO”)
under Section 31(1) of the Competition
Act, 2002

Date 14/06/2022
 
Press Release (347.25 KB)